Skip to main content
Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
91.39
-2.13 (-2.28%)
Mar 9, 2026, 2:30 PM EDT - Market open

Rhythm Pharmaceuticals Revenue

In the year 2025, Rhythm Pharmaceuticals had annual revenue of $189.76M with 45.83% growth. Rhythm Pharmaceuticals had revenue of $57.25M in the quarter ending December 31, 2025, with 36.87% growth.

Revenue (ttm)
$189.76M
Revenue Growth
+45.83%
P/S Ratio
32.85
Revenue / Employee
$458,350
Employees
414
Market Cap
6.24B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025189.76M59.63M45.83%
Dec 31, 2024130.13M52.70M68.06%
Dec 31, 202377.43M53.79M227.56%
Dec 31, 202223.64M20.48M649.46%
Dec 31, 20213.15M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Caris Life Sciences 812.03M
Krystal Biotech 389.13M
Cytokinetics 88.04M
Protagonist Therapeutics 46.02M
Kymera Therapeutics 39.21M
Arcellx 22.29M
CRISPR Therapeutics AG 3.51M
Revenue Rankings

RYTM News

More News